In PWH on antiretroviral therapy with well controlled HIV-replication and preserved CD4+ cell counts, underlying comorbidities and other general risk factors for severe COVID-19-related outcomes appear to play a larger role than HIV-related factors [26,27]. The gene discussed is CD4; the disease is COVID-19.